FACTOR VIIA IMPROVES COAGULOPATHY AND REDUCES PREDICTED MORTALITY IN MASSIVE POSTPARTUM HEMORRHAGE

被引：0
|
作者：
Kalina, Michael [1 ]
Babenko, Christina [1 ]
Fulda, Gerard [2 ]
机构：
[1] Christiana Care Hosp, Newark, DE USA
[2] Christiana Care Hlth Syst, Delaware, OH USA
来源：
CRITICAL CARE MEDICINE | 2009年 / 37卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
817
引用
收藏
页码：A400 / A400
页数：1
相关论文
共 47 条
  • [31] Recombinant factor VIIa reduces rebleed hemorrhage volume in a swine aortotomy model: A randomized double-blinded study
    McMullin, Neil R.
    Hedner, Ulla
    Ezban, Mirella
    Lauritzen, Brian
    Prince, M. Dale
    Holcomb, John B.
    Sondeen, Jill L.
    SHOCK, 2008, 29 (06): : 703 - 708
  • [32] Recombinant factor VIIa improves 42-day but not 5-day mortality from variceal bleeding
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 (8): : 412 - 412
  • [33] Stereotactic IntraCerebral Underwater Blood Aspiration (SCUBA) Improves Survival Following Intracerebral Hemorrhage as Compared with Predicted Mortality
    Shapiro, Steven D.
    Alkayyali, Miryam
    Reynolds, Alexandra
    Reilly, Kaitlin
    Selim, Magdy
    Dangayach, Neha
    Mocco, J.
    Kellner, Christopher P.
    Liang, John W.
    WORLD NEUROSURGERY, 2022, 161 : E289 - E294
  • [34] Use of recombinant factor VIIa in the management of subcapsular liver hematoma and massive hemorrhage complicating pregnancy associated with preeclampsia and HELLP syndrome.
    VanderJagt, TJ
    Merchant, SH
    Mathew, P
    Crookston, KP
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (02) : 277 - 278
  • [35] Local application of active site inhibited factor VIIa significantly reduces thrombus weight and improves patency in a venous experimental thrombosis model
    Holst, J
    Kristensen, AT
    Kristensen, HI
    Bak, H
    Ezban, M
    Hedner, U
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2804 - P2804
  • [36] Astrocyte heme oxygenase-1 reduces mortality and improves outcome after collagenase-induced intracerebral hemorrhage
    Chen-Roetling, Jing
    Kamalapathy, Pramod
    Cao, Yang
    Song, Wei
    Schipper, Hyman M.
    Regan, Raymond F.
    NEUROBIOLOGY OF DISEASE, 2017, 102 : 140 - 146
  • [37] Novel Use Of Aerosolized Intrapulmonary Activated Recombinant Factor Viia To Stabilize Massive Life-Threatening Diffuse Alveolar Hemorrhage As A Bridging Mechanism To Ecmo
    Savajiyani, S.
    Hall, J.
    Liao, D. -W.
    Sparacino, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [38] Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: A pilot study
    Lynn, M
    Jerokhimov, I
    Jewelewicz, D
    Popkin, C
    Johnson, EW
    Rashid, QN
    Brown, M
    Martinowitz, U
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2002, 52 (04): : 703 - 707
  • [39] Normalization of the thromboelastogram (TEG) and cessation of bleeding after infusion of recombinant factor VIIa (rVIIa) in a child with pulmonary hemorrhage and complex Coagulopathy post tissue plasminogen activator (TPA) infusion.
    Boshkov, LK
    Thomas, G
    Kirby, A
    Godder, K
    Tegtmeyer, K
    BLOOD, 2002, 100 (11) : 106B - 106B
  • [40] USE OF RECOMBINANT ACTIVATED FACTOR VIIa IN A SIX-MONTH-OLD CHILD DUE TO MASSIVE HEMORRHAGE DURING ELECTIVE SURGERY FOR CHOROID PLEXUS CARCINOMA: CASE REPORT
    Vesel, Alenka Spindler
    Novak-Jankovic, Vesna
    Maldini, Branka
    Lukanovic, Neva Pozar
    Denic, Kata
    Markovic-Bozic, Jasmina
    Sostaric, Maja
    ACTA CLINICA CROATICA, 2015, 54 (03) : 381 - 387
12345